Pharma IQ Members

Stuart Carroll & Alasdair Williams

Value-Based Pricing in 2012 – Is it Still Worth the Trouble?

As the old aphorism goes, a New Year means a new beginning. It also provides an opportunity for all of us to make New Year resolutions – promises we make to one or more lasting personal goals, projects, or the reforming of a habit. In the world of health policy, this has added meaning. The Government continues to face opposition to its NHS reforms.

by: Stuart Carroll & Alasdair Williams
Published: February 8, 2012
Tags: value-based pricing, VBP, Stuart Carroll, Alasdair Williams, pharmaceutical pricing, Pharmaceutical Price Regulation Scheme, PPRS, NHS reforms, Andrew Lansley, George Osborne, UK Government, NHS drug availability, health economy, health economics, NHS